• Explore /
  • Poster
  • / First-line (1L) immuno-oncology (IO) combination therapies in metastatic renal-cell carcinoma (mRCC): Results from the international mRCC database consortium (IMDC).

First-line (1L) immuno-oncology (IO) combination therapies in metastatic renal-cell carcinoma (mRCC): Results from the international mRCC database consortium (IMDC).

Abstract Poster

Authors

null

Shaan Dudani

Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada

Shaan Dudani , Jeffrey Graham , Connor Wells , Ziad Bakouny , Sumanta K. Pal , Nazli Dizman , Frede Donskov , Camillo Porta , Guillermo de Velasco , Aaron Richard Hansen , Marco Adelmo James Iafolla , Benoit Beuselinck , Ulka N. Vaishampayan , Lori Wood , Elizabeth Chien Hern Liow , Flora Yan , Takeshi Yuasa , Georg A. Bjarnason , Toni K. Choueiri , Daniel Yick Chin Heng

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Nonprostate) Cancer

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Kidney Cancer

Citation

J Clin Oncol 37, 2019 (suppl; abstr 4577)

DOI

10.1200/JCO.2019.37.15_suppl.4577

Abstract #

4577

Poster Bd #

403

Abstract Disclosures

Similar Posters

First Author: Shaan Dudani

First Author: Ana-Alicia Beltran-Bless

Poster

2024 ASCO Genitourinary Cancers Symposium

Erectile function in patients with metastatic renal cell carcinoma treated with first-line therapy.

Erectile function in patients with metastatic renal cell carcinoma treated with first-line therapy.

First Author: Ilya Tsimafeyeu

First Author: Joseph Vento